Posted in M&A / Deals Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions April 17, 2026 Pharmaceutical Business Review The agreement involves Daiichi Sankyo Research Institute Boston and aims to assess the use of Interna’s MNM technology as a delivery enhancer for therapeutic modalities. M&A / DealsRead full story